Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHF Advisory Group, LLC
Latest Disclosed Ownership20,919 shares
Latest Disclosed Value $ 2,915,420
HF Advisory Group, LLC reports 1.67% increase in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - HF Advisory Group, LLC filed a 13F-HR form disclosing ownership of 20,919 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,915,420 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on January 23, 2026 disclosing 20,576 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 20,919 343 1.67 2,915 15.45 0.9935
2026-01-23 2025-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 20,576 712 3.58 2,525 14.56 0.8811
2026-01-16 2025-12-31 13F GILEAD SCIENCES COM 375558103 33,076 13,212 2,538 0.8412
2025-10-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 19,864 1,344 7.26 2,205 7.36 0.8097
2025-07-10 2025-06-30 13F GILEAD SCIENCES COM 375558103 18,520 1,580 9.33 2,053 8.17 0.8114
2025-04-10 2025-03-31 13F GILEAD SCIENCES COM 375558103 16,940 764 4.72 1,898 27.04 0.8294
2025-01-15 2024-12-31 13F GILEAD SCIENCES COM 375558103 16,176 -1,737 -9.70 1,494 -0.47 0.6868
2024-10-30 2024-09-30 13F GILEAD SCIENCES COM 375558103 17,913 -277 -1.52 1,502 20.27 0.6978
2024-07-18 2024-06-30 13F GILEAD SCIENCES COM 375558103 18,190 2,724 17.61 1,248 10.25 0.6454
2024-04-22 2024-03-31 13F GILEAD SCIENCES COM 375558103 15,466 639 4.31 1,133 -5.75 0.6336
2024-01-31 2023-12-31 13F GILEAD SCIENCES COM 375558103 14,827 308 2.12 1,201 10.39 0.7671
2023-10-31 2023-09-30 13F GILEAD SCIENCES COM 375558103 14,519 1,769 13.87 1,088 10.79 0.8070
2023-07-20 2023-06-30 13F GILEAD SCIENCES COM 375558103 12,750 2,219 21.07 983 12.49 0.7765
2023-04-19 2023-03-31 13F GILEAD SCIENCES COM 375558103 10,531 1,626 18.26 874 14.27 0.7755
2023-02-07 2022-12-31 13F GILEAD SCIENCES COM 375558103 8,905 8,905 764 0.7728
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.